<p>In the early trading session on Friday, the Dow Jones Industrial Average's 30 constituent stocks saw Merck rise by 0.7%. This came after U.S. President Trump announced plans to impose a 100% tariff on branded and patented drugs, which could significantly increase costs for pharmaceutical companies without U.S. production capabilities, while putting greater pressure on companies that have not yet started construction of their factories</p>

<p>In the early trading session on Friday, Merck & Co., one of the 30 components of the Dow Jones Industrial Average, rose by 0.7%. This follows U.S. President Trump's plan to impose a 100% tariff on branded and patented drugs, which could significantly increase costs for pharmaceutical companies without U.S. production capabilities, while putting greater pressure on companies that have not yet started building factories</p>

News